Prostate cancer localization with 18fluorine fluorocholine positron emission tomography

Journal of Urology

Volumn 173, Issue 1, 2005, Pages 252-255

  Kwee, Sandi A ^a   Coel, Marc N ^a   Lim, John ^a   Ko, Jehoon P ^a  

^a QUEEN S MEDICAL CENTER   (United States)

Author keywords

Neoplasm staging; Prostate; Prostatic neoplasms; Tomography, emission computed

Indexed keywords

FLUOROCHOLINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; CANCER LOCALIZATION; COMPUTER ASSISTED TOMOGRAPHY; HORMONAL THERAPY; HUMAN; LYMPH NODE DISSECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RETROPERITONEAL DISEASE;

EID: 10344224054     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000142099.80156.85     Document Type: Article

References (20)

1. Gann, P. H., Hennekens, C. H. and Stampfer, M. J.: A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA, 273: 289, 1995
2. Djavan, B., Zlotta, A., Remzi, M., Ghawidel, K., Basharkhah, A., Schulman, C. C. et al: Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol, 163: 1144, 2000
3. Grossfeld, G. D., Latini, D. M., Lubeck, D. P., Broering, J. M., Li, Y. P., Mehta, S. S. et al: Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology, 59: 560, 2002
4. el-Gabry, E. A., Halpern, E. J., Strup, S. E. and Gomella, L. G.: Imaging prostate cancer: current and future applications. Oncology, 15: 325, 2001
5. Ramirez de Molina, A., Rodriguez-Gonzalez, A., Gutierrez, R., Martinez-Pineiro, L., Sanchez, J., Bonilla, F. et al: Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun, 296: 580, 2002
6. Aboagye, E. O. and Bhujwalla, Z. M.: Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res, 59: 80, 1999
7. DeGrado, T. R., Coleman, R. E., Wang, S., Baldwin, S. W., Orr, M. D., Robertson, C. N. et al: Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res, 61: 110, 2001
8. 18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol, 168: 273, 2002
9. DeGrado, T. R., Baldwin, S. W., Wang, S., Orr, M. D., Liao, R. P. and Friedman, H. S.: Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. J Nucl Med, 42: 1805, 2001
10. Lim, J., Dorman, E. and Cabral, C.: Automated production of[18F]FECh and [18F]FCH: preparation and use of [18F]fluoroalkane sulfonates and fluoroalkylation agents. J Label Compd Radiopharm, 46: S403, 2003
11. Hodge, K. K., McNeal, J. E., Terris, M. K. and Stamey, T. A.: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol, 142: 71, 1989
12. Ackerstaff, E., Pflug, B. R., Nelson, J. B. and Bhujwalla, Z. M.: Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res, 61: 3599, 2001
13. 31P magnetic resonance spectroscopy. J Urol, 150: 2019, 1993
14. Kurhanewicz, J., Vigneron, D. B., Hricak, H., Narayan, P., Carroll, P. and Nelson, S. J.: Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology, 198: 795, 1996
15. Swanson, M. G., Vigneron, D. B., Tabatabai, Z. L., Males, R. G., Schmitt, L., Carroll, P. R. et al: Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med, 50: 944, 2003
16. Fichtinger, G., DeWeese, T. L., Patriciu, A., Tanacs, A., Mazilu, D. and Anderson, J. H.: System for robotically assisted prostate biopsy and therapy with intraoperative CT guidance. Acad Radiol, 9: 60, 2002
17. Mizowaki, T., Cohen, G. N., Fung, A. Y. and Zaider, M.: Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int J Radiat Oncol Biol Phys, 54: 1558, 2002
18. Epstein, J. I., Walsh, P. C., Akingba, G., Carter, H. B.: The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer. J Urol, 162: 1649, 1999
19. Naughton, C. K., Miller, D. C., Mager, D. E., Ornstein, D. K. and Catalona, W. J.: A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol, 164: 388, 2000
20. Salomon, L., Colombel, M., Patard, J. J., Lefrere-Belda, M. A., Bellot, J., Chopin, D. et al: Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping. Eur Urol, 35: 289, 1999